Related Experiment Videos
The withdrawal of temafloxacin. Are there implications for other quinolones?
1Department of Microbial Diseases, Nottingham City Hospital, England.
Drug Safety
|January 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
GRACE and the development of an education and training curriculum.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2012
Sporicides for Clostridium difficile: the devil is in the detail.
The Journal of hospital infection·2011
Safety and efficacy of glycopeptide antibiotics.
The Journal of antimicrobial chemotherapy·2005
Hepatitis C virus infection.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2005
Immunomodulating activity of rifampicin.
Journal of chemotherapy (Florence, Italy)·2004
Introduction: standards of antibacterial performance.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2004
The WHO-ISoP Pharmacovigilance Curriculum: 2026 Update.
Drug safety·2026
The legally protected fungi and lichens in the EU.
IMA fungus·2026
Albendazole Monotherapy and Spleen Preservation in an Adolescent with Isolated Primary Splenic Cystic Echinococcosis: A Case Report.
Pathogens (Basel, Switzerland)·2026